Robert LeBoyer
Stock Analyst at Noble Capital Markets
(0)
# 2930
Out of 5,312 analysts
20
Total ratings
31.25%
Success rate
0.69%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
TNXP Tonix Pharmaceutical... | Reiterates: Outperform | 70 70 | 17 | 311.76% | 2 | Mar 20, 2025 | |
NTRB Nutriband | Initiates Coverage On: Outperform | 13 | 4.75 | 173.68% | 1 | Jan 22, 2025 | |
GOVX Geovax Labs | Maintains: Outperform | 6 10 | 1.03 | 870.87% | 2 | Aug 19, 2024 | |
UNCY Unicycive Therapeuti... | Initiates Coverage On: Outperform | 6 | 0.53 | 1032.08% | 1 | Feb 14, 2024 | |
CVKD Cadrenal Therapeutic... | Initiates Coverage On: Outperform | 60 | 14.58 | 311.52% | 1 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 10 | 2.76 | 262.32% | 1 | Sep 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 14 | 1.49 | 839.6% | 1 | Feb 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 1 | Sep 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 150 | n/a | n/a | 1 | Oct 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 8 | 0.41 | 1851.22% | 2 | Aug 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 120 | 0.74 | 16116.22% | 1 | Jan 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Oct 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 12 | 8.56 | 40.19% | 1 | Sep 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 825000 | n/a | n/a | 1 | Aug 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Apr 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 15 | 4.26 | 252.11% | 2 | Mar 8, 2018 |